The Company entered into a licensing agreement for a license to use the Cell-in-a-Box^® technology to develop therapies involving Cannabis for a total amount of $2,000,000 “Upfront Payment” for the license (see Note 8). As of October 31, 2016, the Company’s license agreement obligation was paid in full. As of April 30, 2016, the Company’s license obligation was $150,000.